pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·Aug 28·1 min read
save

Vaccine claims dominate federal autism advisory committee meeting, sidelining research funding plan

Aug 28, 2026·read at STAT ↗Negative

At a recent meeting of the federal autism advisory committee, members spent most of the time discussing vaccines as a possible trigger for autism.

The discussion eclipsed the committee’s intended agenda, which was to consider a proposal to increase federal funding for autism research.

Although the scientific consensus rejects a link between vaccines and autism, several public members cited vaccines and other factors such as glutamate or aspirin as potential causes, and the panel did not challenge those statements.

The strategic plan under review does not mention vaccines, highlighting a disconnect between the committee’s focus and its formal objectives.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “Vaccines take center stage at federal autism advisory committee”

read at STAT ↗
510 words · retrieved Aug 28
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
Ultragenyx Pharmaceutical Inc.
drugs
BUTALBITAL, ASPIRIN, CAFFEINE, AND CODEINE PHOSPHATE2SYNALGOS-DC2Stem Cell Therapy for Coronavirus Disease 2019 (COVID-19)2aspirin2
topics
Vaccines13AdCom5Psychiatry & CNS2ImmunologyRare Disease

related stories

  • Apr 28Predicting consequences of new hepatitis B vaccine recsSTAT
  • Sep 22Lexeo takes up the Mantle in $8M acquisition for Friedreich ataxia assetsFierce Biotech
  • Sep 14After a brief storm of political headwinds, mRNA is back with strong momentumBioSpace
  • Sep 1GSK to launch Phase 3 trial for mRNA-based flu vaccine amid resurgence for the modalityBioSpace
  • Aug 28STAT+: In autopsy of failed heart disease study, AstraZeneca raises broader questions about silencer drugsSTAT